LSB

LakeShore Biopharma
LSB

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

LSB was delisted on the 19th of September, 2025.

Back to rankings

14 hedge funds and large institutions have $20.4M invested in LakeShore Biopharma in 2023 Q1 according to their latest regulatory filings, with 14 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$6.88M
2
+$4.35M
3
+$2.57M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$1.86M
5
HA
HHLR Advisors
Cayman Islands
+$1.2M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$6.88M
2
$4.35M
3
$2.9M
4
$2.57M
5
$1.86M
6
$1.2M
7
$546K
8
$37K
9
$32K
10
$21.8K
11
$19.2K
12
$7.79K
13
$798
14
$160